TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 196 filers reported holding TESARO INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,430,000 | -21.1% | 77,132 | +1.4% | 0.00% | -50.0% |
| Q1 2018 | $4,346,000 | +9.6% | 76,063 | +59.0% | 0.00% | 0.0% |
| Q4 2017 | $3,965,000 | -34.9% | 47,840 | +1.3% | 0.00% | -33.3% |
| Q3 2017 | $6,094,000 | -7.1% | 47,203 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $6,561,000 | -9.1% | 46,914 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,220,000 | -41.6% | 46,924 | -49.0% | 0.00% | -50.0% |
| Q4 2016 | $12,371,000 | +23.2% | 91,994 | -8.2% | 0.01% | +20.0% |
| Q3 2016 | $10,043,000 | -39.2% | 100,194 | -49.0% | 0.01% | -37.5% |
| Q2 2016 | $16,529,000 | +31.7% | 196,651 | -31.0% | 0.01% | +14.3% |
| Q1 2016 | $12,553,000 | -14.8% | 285,107 | +1.3% | 0.01% | -12.5% |
| Q4 2015 | $14,731,000 | +29.6% | 281,563 | -0.7% | 0.01% | +33.3% |
| Q3 2015 | $11,368,000 | -99.9% | 283,503 | -10.5% | 0.01% | -33.3% |
| Q2 2015 | $18,628,258,000 | -6.2% | 316,861 | -8.4% | 0.01% | -10.0% |
| Q1 2015 | $19,863,671,000 | +59.2% | 346,057 | +3.2% | 0.01% | +66.7% |
| Q4 2014 | $12,475,980,000 | +123731.1% | 335,466 | -10.4% | 0.01% | +20.0% |
| Q3 2014 | $10,075,000 | – | 374,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
| NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
| Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
| Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
| Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
| SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
| BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |